Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the practice of genetic testing in epilepsy for determining diagnostics and treatment. Genetic testing…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the importance of spending adequate time to discuss the social implications of epilepsy and…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses evaluation and management of children with epilepsy. Understanding the underlying disorder and subtype of…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the treatment of epilepsy in special populations, including children and the elderly. Older patients…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses his book, Epilepsy 199 Answers:Third EditionA Doctor Responds To His Patients Questions. Get the…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the methods for determining when and how to discontinue the usage of medications in…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the steps to determine if and why a patient suffers from refractory epilepsy and…
NEW YORK (Reuters Health) – Injecting bone cement into acute osteoporotic compression fractures leads to almost immediate and long-lasting pain relief – and at reasonable cost, a European…
NEW YORK (Reuters Health) – The response rate with standard treatment of hepatitis C infection is doubled when a hepatitis C virus (HCV) protease inhibitor, boceprevir, is added…
Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the selection of appropriate initial drug therapy for a patient who has been determined…
